QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

35,147 signal articles · 105 in last 24h · 178,672 total before filter · latest 55m ago

105last 24h

3127last 7d

510● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1820 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: LLYsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

Moby89d agoneutral

Absci Corporation Q2 2026 Earnings Call Summary

MarketBeat89d agoneutral

Absci Q2 Earnings Call Highlights

The Wall Street Journal89d agoneutral

Healthcare Investing Is Now an AI Short in Disguise

ABBV BMY JNJ LLY UNH

Trefis90d agoneutral

What Analysts Really Pressed LLY On This Quarter

ABBV AMGN JNJ LLY MRK PFE

Benzinga91d agoneutral

Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients

MarketBeat92d agoneutral

Eli Lilly and Company Q2 Earnings Call Highlights

GuruFocus.com93d agoneutral

Novo Nordisk Stock Rises After GLP-1 Antitrust Win

GuruFocus.com93d agoneutral

Lilly and Novo Win a Key GLP-1 Antitrust Fight

Reuters93d agoneutral

Morning Bid: Dealjà vu

AMD CAT COP LLY MRK

The Wall Street Journal94d agoneutral

The Race to Come Up With the Next Big Sleep Drug

The Wall Street Journal94d agoneutral

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients

Zacks94d agoneutral

LLY Q2 Earnings Call Raises Outlook as Foundayo Gains Traction

The Wall Street Journal94d agoneutral

Health Care Roundup: Market Talk

Benzinga95d agoneutral

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings

Moby95d agoneutral

Eli Lilly and Company Q2 2026 Earnings Call Summary

Moby95d agoneutral

Charles River Laboratories International, Inc. Q2 2026 Earnings Call Summary

The Wall Street Journal95d agoneutral

Health Care Roundup: Market Talk

Yahoo Finance95d agoneutral

The companies defying macro uncertainty and raising guidance: AlphaCheck

AMD ANET CRWD INTC LLY NEM SPCX ^DJI+1

Zacks95d agoneutral

Lilly (LLY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

MT Newswires95d agoneutral

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Corporate Earnings, Hormuz Reopening Hopes

GLD IGV IVV IWM LLY PSX QQQ SOXX+7

MT Newswires95d agoneutral

Stocks Rise Pre-Bell Amid Growing Hopes for Hormuz Deal; Traders Await More Corporate Earnings

ANET APP CVS DASH DIS EBAY KHC LLY+8

Barrons.com95d agoneutral

Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles

Investing.com95d agoneutral

Eli Lilly shares pop as weight-loss drug demand fuels guidance hike

The Wall Street Journal95d agoneutral

Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand

The Wall Street Journal95d agoneutral

Jobs Report, Berkshire Earnings: What to Watch the Rest of the Week

ABNB COP CVS DASH DDOG EBAY KHC LLY+7

Barrons.com96d agoneutral

CVS’s Turnaround Faces Its Next Test

Barrons.com96d agoneutral

Novo Nordisk Raises Earnings Guidance. The Stock Sinks.

Zacks96d agoneutral

Pfizer (PFE) Q2 Earnings and Revenues Top Estimates

Barrons.com96d agoneutral

AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open

ABBV BMY LLY PFE

Investopedia96d agoneutral

Here’s How Much Traders See Eli Lilly Stock Moving After Earnings